Disease states of GH excess (e.g., acromegaly) and GH deficiency (GHD) (e.g., congenital isolated GHD) are characterized by increased and decreased GH and IGF-I levels, where the GH/IGF-I relationship is reflected by a primary association (high GH and high IGF-I for acromegaly and low GH and low IGF-I for GHD)
Levodopa, as a dopamine precursor, has been the frontline treatment for this disease (3), and although it improves symptoms in the short term, it requires high doses in the long term, which is associated with side effects resulting in reduced patients' life quality (10)
Meto's Longevity Panel is designed precisely to characterise the hormonal baseline including IGF-1 that should anchor any such protocol
Other promising NE inhibitors have also been stopped for various reasons
In experimental research designs where both connective tissue signaling and cellular mobility pathways are evaluated together, some laboratories reference combined peptide materials
